Completed

Evaluation of the Precision and Accuracy of OCT Measurements in Retinal and Glaucoma Patients

0 criteria met from your profileSee at a glance how your profile meets each eligibility criteria.
What is being collected

Data Collection

Collected from today forward - Prospective
Who is being recruted

Eye Diseases

+ Ocular Hypertension

+ Glaucoma

Over 18 Years
See all eligibility criteria
How is the trial designed

Cohort

Tracking disease incidence in order to identify risk factors and understand disease progression over time.
Observational
Study Start: February 2013
See protocol details

Summary

Principal SponsorOptovue
Last updated: January 22, 2014
Sourced from a government-validated database.Claim as a partner

Study start date: February 1, 2013

Actual date on which the first participant was enrolled.

The purpose of the study is to repeatability, reproducibility and agreement of eye measurements in retina and glaucoma patients using OCT technology. There will be a series of measurements acquired from one eye on at least 2 different OCT devices. All testing will be completed in one visit.

NCT01806402
Principal SponsorOptovue
Last updated: January 22, 2014
Sourced from a government-validated database.Claim as a partner

Protocol

This section provides details of the study plan, including how the study is designed and what the study is measuring.
Design Details

135 patients to be enrolled

Total number of participants that the clinical trial aims to recruit.

Cohort

These studies follow a group of individuals with common characteristics (such as a condition or birth year) over a specific period to study health outcomes or exposures.

Eligibility

Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.
Conditions
Criteria

Any sex

Biological sex of participants that are eligible to enroll.

Over 18 Years

Range of ages for which participants are eligible to join.

Healthy volunteers not allowed

If individuals who are healthy and do not have the condition being studied can participate.

Conditions

Pathology

Eye DiseasesOcular HypertensionGlaucoma

Criteria

Inclusion Criteria: Inclusion Criterea: At least 18 years of age Able and willing to provide consent Willing to complete the required examinations and visits Best corrected visual acuity equal or better than 20/100 Retina subject must have clinical diagnosis of retinal pathology Glaucoma subjects must have clinical diagnosis of glaucoma Exclusion Criteria: Unable to complete the required examinations and visits Poor OCT image quality as a result of media opacity, extreme refractive error or pathologies in the anterior segment Confounding pathology requiring surgical treatment or medical intervention

Study Plan

Find out more about all the medication administered in this study, their detailed description and what they involve.
Treatment Groups
Study Objectives

2 intervention groups are designated in this study

This study does not include a placebo group 

Treatment Groups

Study Objectives

Primary Objectives

Study Centers

These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.

This study has 3 locations

Pacific Eye Specialists

Daly City, United StatesOpen Pacific Eye Specialists in Google Maps

North Bay Eye Associates

Petaluma, United States

West Coast Retinal Medical Group

Walnut Creek, United States
Completed3 Study Centers
Evaluation of the Precision and Accuracy of OCT Measurements in Retinal and Glaucoma Patients | PatLynk